Abstract Objective To assess the safety and efficacy of rituximab in a randomized, double‐blind, placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory polymyositis (PM) and adults and children with refractory dermatomyositis (DM) were enrolled. Entry criteria i...
No comments yet
Be the first to share your thoughts!